You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
For over 20 years, we have been deeply committed to delivering innovative solutions designed to help clinicians reach more patients and heal more hearts.
Research & Publications
With approximately 150 electrophysiology centres globally and a heritage of pioneering treatment in the field of EP, we are committed to advancing quality of care.
Education & Awareness
We enable lifelong learning for those on the frontlines of care at J&J Institute and strive to deliver AF education and awareness among clinicians and the general public.
Meet Ipke, who believes that “it's everyone’s right to live atrial fibrillation-free"
On a Mission to Cure Atrial Fibrillation, innovation is at the heart of our organization and embedded in all we do. It fuels our discovery and development of new products and also extends to our collaborations, education and community efforts to bring new solutions to those in need.
Are you aware of the different treatment options for AF patients? Make sure to discuss them with your doctor.
VISTAX Prospective, Multicenter, Nonrandomized Study1
PRECEPT Prospective, Multicenter, Nonrandomized Study2
ATTEST Prospective, Multicenter, Randomized Controlled Study3
More Clinical Evidence
You are entering a rotating card carousel. Navigate the items by using the previous/next buttons.
07 March 2023
Biosense Webster Begins SmartfIRE Clinical Trial to Evaluate its First Dual Energy Catheter to Treat Atrial Fibrillation
28 September 2021
Biosense Webster Announces Completion of Atrial Fibrillation Cases Using Novel HELIOSTAR™ Balloon Ablation Catheter
27 August 2021
Biosense Webster inspIRE Clinical Study Shows 100% Acute Procedural Success in Initial Data
27 October 2020
Comparing the Effectiveness of Different Catheter Ablation Technologies to Help Atrial Fibrillation (AF) Patients Live ‘Disease Free’
27 August 2020
Biosense Webster Launches CARTO® 3 System Version 7 and the CARTO PRIME™ Mapping Module to Advance Treatment of Complex Arrhythmias
26 March 2020
Commited to our Community
AF is the new millennium epidemic that affects millions of lives, mostly affecting the middle-aged and elderly. Watch this video to understand the full scope of the burden of the disease.